Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built their fortunes by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.
Identifying genuine bargains from value traps is something many investors struggle with, which is why we started StockStory - to help you find the best companies. Keeping that in mind, here are three value stocks with poor fundamentals and some alternatives you should consider instead.
Health Catalyst (HCAT)
Forward P/S Ratio: 0.3x
Built on its "Health Catalyst Flywheel" methodology that emphasizes measurable outcomes, Health Catalyst (NASDAQ:HCAT) provides data and analytics technology and services that help healthcare organizations manage their data and drive measurable clinical, financial, and operational improvements.
Why Is HCAT Risky?
- 2.5% annual revenue growth over the last two years was slower than its software peers
- Customer acquisition costs take a while to recoup, making it difficult to justify sales and marketing investments that could increase revenue
- Cash-burning tendencies make us wonder if it can sustainably generate shareholder value
At $1.17 per share, Health Catalyst trades at 0.3x forward price-to-sales. If you’re considering HCAT for your portfolio, see our FREE research report to learn more.
NXP Semiconductors (NXPI)
Forward P/E Ratio: 13.8x
Spun off from Dutch electronics giant Philips in 2006, NXP Semiconductors (NASDAQ: NXPI) is a designer and manufacturer of chips used in autos, industrial manufacturing, mobile devices, and communications infrastructure.
Why Does NXPI Give Us Pause?
- Annual sales declines of 3.9% for the past two years show its products and services struggled to connect with the market during this cycle
- Estimated sales growth of 10.6% for the next 12 months is soft and implies weaker demand
NXP Semiconductors is trading at $192.71 per share, or 13.8x forward P/E. Check out our free in-depth research report to learn more about why NXPI doesn’t pass our bar.
Lamb Weston (LW)
Forward P/E Ratio: 15.5x
Best known for its Grown in Idaho brand, Lamb Weston (NYSE:LW) produces and distributes potato products such as frozen french fries and mashed potatoes.
Why Is LW Not Exciting?
- Core business is underperforming as its organic revenue has disappointed over the past two years, suggesting it might need acquisitions to stimulate growth
- Sales are projected to remain flat over the next 12 months as demand decelerates from its three-year trend
- Easily substituted products (and therefore stiff competition) result in an inferior gross margin of 22.9% that must be offset through higher volumes
Lamb Weston’s stock price of $41.13 implies a valuation ratio of 15.5x forward P/E. Dive into our free research report to see why there are better opportunities than LW.
High-Quality Stocks for All Market Conditions
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meeting near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.